Identification Generic Name (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine DrugBank Accession Number DB03216 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine (DB03216) ×  Close Weight Average: 233.2266  Monoisotopic: 233.091274621  Chemical Formula C 10 H 11 N 5 O 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Adenosylhomocysteinase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 1,3-substituted cyclopentyl purine nucleosides. These are nucleoside analogues with a structure that consists of a cyclobutane that is substituted a the 1-position with a hydroxyl group and at the 3-position with either a purine base. Kingdom Organic compounds Super Class Nucleosides, nucleotides, and analogues Class Nucleoside and nucleotide analogues Sub Class Cyclopentyl nucleosides Direct Parent 1,3-substituted cyclopentyl purine nucleosides Alternative Parents 6-aminopurines  /  Aminopyrimidines and derivatives  /  N-substituted imidazoles  /  Imidolactams  /  Heteroaromatic compounds  /  Secondary alcohols  /  1,2-diols  /  Azacyclic compounds  /  Primary amines  /  Organopnictogen compounds  /  Hydrocarbon derivatives 
 
 
  show 1 more Substituents 1,2-diol  /  1,3-substituted cyclopentyl purine nucleoside  /  6-aminopurine  /  Alcohol  /  Amine  /  Aminopyrimidine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Azole  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidazole  /  Imidazopyrimidine  /  Imidolactam  /  N-substituted imidazole  /  Organic nitrogen compound  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary amine  /  Purine  /  Pyrimidine  /  Secondary alcohol 
 
 
  show 15 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key RQPALADHFYHEHK-CHKWXVPMSA-N InChI InChI=1S/C10H11N5O2/c11-9-7-10(13-3-12-9)15(4-14-7)5-1-2-6(16)8(5)17/h1-6,8,16-17H,(H2,11,12,13)/t5-,6+,8+/m1/s1 IUPAC Name (1S,2S,5R)-5-(6-amino-9H-purin-9-yl)cyclopent-3-ene-1,2-diol SMILES NC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1O References General References Not Available External Links PubChem Compound 5287610 PubChem Substance 46505345 ChemSpider 4449940 PDBe Ligand ADC PDB Entries 1a7a Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 6.86 mg/mL ALOGPS logP -0.63 ALOGPS logP -1.2 Chemaxon logS -1.5 ALOGPS pKa (Strongest Acidic) 13.19 Chemaxon pKa (Strongest Basic) 4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 110.08 Å 2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 61.44 m 3 ·mol -1 Chemaxon Polarizability 22.43 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9965 Blood Brain Barrier + 0.9207 Caco-2 permeable - 0.513 P-glycoprotein substrate Non-substrate 0.6781 P-glycoprotein inhibitor I Non-inhibitor 0.9326 P-glycoprotein inhibitor II Non-inhibitor 0.7593 Renal organic cation transporter Non-inhibitor 0.9226 CYP450 2C9 substrate Non-substrate 0.8444 CYP450 2D6 substrate Non-substrate 0.8247 CYP450 3A4 substrate Non-substrate 0.6799 CYP450 1A2 substrate Non-inhibitor 0.8058 CYP450 2C9 inhibitor Non-inhibitor 0.8368 CYP450 2D6 inhibitor Non-inhibitor 0.8086 CYP450 2C19 inhibitor Non-inhibitor 0.6535 CYP450 3A4 inhibitor Non-inhibitor 0.9158 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7592 Ames test AMES toxic 0.7172 Carcinogenicity Non-carcinogens 0.9193 Biodegradation Not ready biodegradable 0.9964 Rat acute toxicity 2.5712 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9502 hERG inhibition (predictor II) Non-inhibitor 0.8383    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 5830 N/A N/A A30115 IC 50 (nM) 8700 N/A N/A A30114 Ki (nM) 41 N/A N/A A30113 Ki (nM) 49 N/A N/A A30112 
 
 
  Details 
 
 
   Binding Properties 1.  Adenosylhomocysteinase Kind Protein Organism Humans Pharmacological action Unknown General Function Nad binding Specific Function Adenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylation... Gene Name AHCY Uniprot ID P23526 Uniprot Name Adenosylhomocysteinase Molecular Weight 47715.715 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 